State of New Jersey Common Pension Fund D Invests $1.97 Million in Surgery Partners, Inc. (NASDAQ:SGRY)

State of New Jersey Common Pension Fund D bought a new position in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 61,033 shares of the company's stock, valued at approximately $1,968,000.

A number of other institutional investors have also modified their holdings of SGRY. Bamco Inc. NY raised its stake in shares of Surgery Partners by 100.0% during the first quarter. Bamco Inc. NY now owns 90,000 shares of the company's stock worth $2,685,000 after purchasing an additional 45,000 shares during the last quarter. Lombard Odier Asset Management Europe Ltd purchased a new position in Surgery Partners during the 2nd quarter worth $4,163,000. Rhumbline Advisers lifted its stake in shares of Surgery Partners by 19.6% in the 2nd quarter. Rhumbline Advisers now owns 127,952 shares of the company's stock worth $3,044,000 after acquiring an additional 20,963 shares during the period. Janus Henderson Group PLC boosted its holdings in shares of Surgery Partners by 7,987.1% in the first quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company's stock valued at $74,701,000 after acquiring an additional 2,473,282 shares in the last quarter. Finally, Point72 Asset Management L.P. purchased a new stake in shares of Surgery Partners in the second quarter valued at about $29,288,000.

Wall Street Analyst Weigh In

A number of brokerages recently commented on SGRY. Royal Bank of Canada restated an "outperform" rating and issued a $49.00 price objective on shares of Surgery Partners in a research report on Wednesday, August 7th. Citigroup reduced their price target on Surgery Partners from $38.00 to $36.00 and set a "buy" rating for the company in a report on Wednesday, August 7th. Cantor Fitzgerald restated an "overweight" rating and issued a $43.00 price target on shares of Surgery Partners in a research note on Friday, October 4th. Macquarie cut their price objective on Surgery Partners from $35.00 to $34.00 and set an "outperform" rating for the company in a research report on Wednesday, November 13th. Finally, KeyCorp started coverage on Surgery Partners in a report on Friday, October 11th. They issued a "sector weight" rating for the company. One analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $40.71.

Surgery Partners Price Performance

SGRY stock traded down $1.12 during midday trading on Monday, hitting $21.83. 2,503,588 shares of the stock were exchanged, compared to its average volume of 957,451. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.69 and a current ratio of 1.80. The stock has a market cap of $2.77 billion, a price-to-earnings ratio of -47.48, a PEG ratio of 16.86 and a beta of 2.76. Surgery Partners, Inc. has a fifty-two week low of $21.54 and a fifty-two week high of $36.92. The stock's 50-day moving average price is $30.62 and its 200-day moving average price is $28.48.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.25 by ($0.06). The business had revenue of $770.40 million for the quarter, compared to analyst estimates of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The business's revenue was up 14.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.15 EPS. Research analysts predict that Surgery Partners, Inc. will post 0.83 earnings per share for the current year.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.